Curanex PharmaceuticalsCURX
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 11 institutions reported holding Curanex Pharmaceuticals Inc. (CURX) in their 13F filings, up 1 from Q3 2025. 6 opened new positions and 5 sold out. The largest holders were Citadel Advisors ($34K), DRW Securities, LLC ($24K) and Two Sigma Investments, LP ($20K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Curanex Pharmaceuticals Inc.
- CUSIP
- 23126K106
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $81K |
| Exits | 5 | $55K |
All 13F filers, Q3 2025 → Q4 2025: 286,960 shares bought and 147,924 shares sold, net +139,036 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Citadel Advisors | 0.00% | Add +62.8% | 104,278 | $34K |
| DRW Securities, LLC | 0.00% | New | 71,553 | $24K |
| Two Sigma Investments, LP | 0.00% | New | 61,102 | $20K |
| Renaissance Technologies | 0.00% | New | 59,297 | $20K |
| XTX Topco Ltd | 0.00% | New | 42,385 | $14K |
| Jane Street Group, LLC | 0.00% | Reduce -29.2% | 24,990 | $8K |
| Geode Capital Management, LLC | 0.00% | No change | 18,670 | $6K |
| Jump Financial, LLC | 0.00% | Reduce -35.8% | 17,451 | $6K |
| UBS Group AG | 0.00% | Reduce -79.9% | 12,991 | $4K |
| HRT Financial LP | 0.00% | New | 12,378 | $4K |
| Bank of America Corp. | 0.00% | New | 34 | $11 |
"% of holder's portfolio" is CURX's weight in each manager's 13F, not the share of Curanex Pharmaceuticals Inc. the manager owns.